Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Plotkin

Showing results (431-440 of 474) with videos related to

Pageof 48
Sort By:
Pediatric Infectious Disease|May 1, 1986
Vancomycin pharmacokinetics in infants: relationships to indices of maturationD H Schaible, M L Rocci, G A Alpert, et al.
Vaccine|June 28, 2001
Optimization of DNA immunization against human cytomegalovirusV Endrész, K Burián, K Berencsi, et al.
Vaccine|July 2, 2021
Evidence for antibody as a protective correlate for COVID-19 vaccinesKristen A Earle, Donna M Ambrosino, Andrew Fiore-Gartland, et al.
The Journal of Infectious Diseases|March 6, 2020
The Status of Vaccine Development Against the Human CytomegalovirusStanley A Plotkin, Dai Wang, Abdel Oualim, et al.
Developments in Biological Standardization|January 1, 1995
The safety and use of canarypox vectored vaccinesS A Plotkin, M Cadoz, B Meignier, et al.
The Lancet. Infectious Diseases|October 11, 2015
Global incidence of serogroup B invasive meningococcal disease: a systematic reviewShruti Sridhar, Brian Greenwood, Christopher Head, et al.
Vaccine|March 17, 1999
Induction of human cytomegalovirus (HCMV)-glycoprotein B (gB)-specific neutralizing antibody and phosphoprotein 65 (pp65)-specific cytotoxic T lymphocyte responses by naked DNA immunizationV Endresz, L Kari, K Berencsi, et al.
Transplantation|December 15, 1994
Multicenter trial of Towne strain attenuated virus vaccine in seronegative renal transplant recipientsS A Plotkin, R Higgins, J B Kurtz, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|September 1, 1994
Early region 3-replacement adenovirus recombinants are less pathogenic in cotton rats and mice than early region 3-deleted virusesK Berencsi, A Uri, T Valyi-Nagy, et al.
Vaccine|March 18, 2003
Serological response and poliovirus excretion following different combined oral and inactivated poliovirus vaccines immunization schedulesIsabelle Parent du Châtelet, Anwar T Merchant, Susan Fisher-Hoch, et al.
Pageof 48

Showing results (431-440 of 474) with videos related to

Sort By:
Pageof 48
Pediatric Infectious Disease|May 1, 1986
Vancomycin pharmacokinetics in infants: relationships to indices of maturationD H Schaible, M L Rocci, G A Alpert, et al.
Vaccine|June 28, 2001
Optimization of DNA immunization against human cytomegalovirusV Endrész, K Burián, K Berencsi, et al.
Vaccine|July 2, 2021
Evidence for antibody as a protective correlate for COVID-19 vaccinesKristen A Earle, Donna M Ambrosino, Andrew Fiore-Gartland, et al.
The Journal of Infectious Diseases|March 6, 2020
The Status of Vaccine Development Against the Human CytomegalovirusStanley A Plotkin, Dai Wang, Abdel Oualim, et al.
Developments in Biological Standardization|January 1, 1995
The safety and use of canarypox vectored vaccinesS A Plotkin, M Cadoz, B Meignier, et al.
The Lancet. Infectious Diseases|October 11, 2015
Global incidence of serogroup B invasive meningococcal disease: a systematic reviewShruti Sridhar, Brian Greenwood, Christopher Head, et al.
Vaccine|March 17, 1999
Induction of human cytomegalovirus (HCMV)-glycoprotein B (gB)-specific neutralizing antibody and phosphoprotein 65 (pp65)-specific cytotoxic T lymphocyte responses by naked DNA immunizationV Endresz, L Kari, K Berencsi, et al.
Transplantation|December 15, 1994
Multicenter trial of Towne strain attenuated virus vaccine in seronegative renal transplant recipientsS A Plotkin, R Higgins, J B Kurtz, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|September 1, 1994
Early region 3-replacement adenovirus recombinants are less pathogenic in cotton rats and mice than early region 3-deleted virusesK Berencsi, A Uri, T Valyi-Nagy, et al.
Vaccine|March 18, 2003
Serological response and poliovirus excretion following different combined oral and inactivated poliovirus vaccines immunization schedulesIsabelle Parent du Châtelet, Anwar T Merchant, Susan Fisher-Hoch, et al.
Pageof 48